"There are enough reports of it, enough interest in it, that we actually did-ivermectin, in particular-did engage in sort of a better preclinical study of its properties and its ability to kill cancer cells and we'll probably have those results in a few months. So we are taking it seriously."
"It's not going to be a cure-all for cancer,"
"I can tell you again, it's not a really strong signal."
The National Cancer Institute is using federal funds to study whether ivermectin can cure cancer. Ivermectin is an inexpensive, off-patent anti-parasitic drug previously promoted by fringe groups as a COVID-19 treatment despite large, high-quality trials showing no efficacy. No scientific evidence supports ivermectin as a cancer cure or justifies the federal expenditure. Anti-vaccine Health Secretary Robert F. Kennedy Jr. has enabled fringe medical figures to hold influential positions. NCI director Anthony Letai said the institute conducted improved preclinical studies on ivermectin's ability to kill cancer cells and expected results within months while cautioning against high expectations.
Read at Ars Technica
Unable to calculate read time
Collection
[
|
...
]